{"id":50714,"date":"2026-11-11T19:48:50","date_gmt":"2026-11-11T17:48:50","guid":{"rendered":"https:\/\/www.channelafrica.co.za\/channelafrica\/?post_type=news&#038;p=50714"},"modified":"2026-11-11T19:55:24","modified_gmt":"2026-11-11T17:55:24","slug":"aspen-pharmacare-wins-approval-for-generic-semaglutide-in-brazil-sa","status":"publish","type":"news","link":"https:\/\/www.channelafrica.co.za\/channelafrica\/news\/aspen-pharmacare-wins-approval-for-generic-semaglutide-in-brazil-sa\/","title":{"rendered":"Aspen Pharmacare wins approval for generic semaglutide in Brazil, SA"},"content":{"rendered":"<div>South Africa&#8217;s (SA) Aspen Pharmacare said on Wednesday it \u200bhad received regulatory approval in Brazil \u200cand SA for its generic injectable semaglutide, paving the way for launches in two key emerging \u200bmarkets.<\/div>\n<div><\/div>\n<div>Aspen is betting on generic versions of \u200bsemaglutide, the active ingredient in Novo Nordisk&#8217;s diabetes drug Ozempic and weight-loss treatment Wegovy, \u200bto drive growth in emerging markets and \u200bselected international markets.<\/div>\n<div><\/div>\n<div>The company said it expects to begin commercialising the product in Canada, Brazil and SA \u200bin the coming months after semaglutide lost \u200bpatent protection, triggering a race among drugmakers to launch lower-cost \u200cversions.<\/div>\n<div><\/div>\n<div>In \u2060SA, sales of GLP-1 medicines have grown to nearly R3 billion\u00a0 ($182 million), with Eli Lilly&#8217;s Mounjaro accounting for more than \u200bhalf of \u200bthe market, \u2060according to Aspen, highlighting strong demand for obesity and diabetes treatments.<\/div>\n<div><\/div>\n<div>Aspen is \u200bLilly&#8217;s distributor for Mounjaro in sub-Saharan \u200bAfrica.<\/div>\n<div><\/div>\n<div>The \u2060company is sourcing the active pharmaceutical ingredient from third-party suppliers, including India&#8217;s Dr. Reddy&#8217;s Laboratories for \u200bthe Canadian market.<\/div>\n<div><\/div>\n<div><\/div>\n<div><\/div>\n<div>&#8211;SABC&#8211;<\/div>\n","protected":false},"featured_media":50715,"template":"","meta":{"_acf_changed":false,"_members_access_role":[],"_members_access_error":"","_links_to":"","_links_to_target":""},"news-type":[26],"class_list":["post-50714","news","type-news","status-publish","has-post-thumbnail","hentry","news-type-general_news","entry"],"acf":{"short_description":"In \u2060SA, sales of GLP-1 medicines have grown to nearly R3 billion\u00a0 ($182 million).","published_date":"","news_description":"In \u2060SA, sales of GLP-1 medicines have grown to nearly R3 billion\u00a0 ($182 million).","form_embed":"","author":"","image_caption":""},"_links":{"self":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/50714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":2,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/50714\/revisions"}],"predecessor-version":[{"id":50717,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/50714\/revisions\/50717"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/media\/50715"}],"wp:attachment":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/media?parent=50714"}],"wp:term":[{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news-type?post=50714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}